Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Novonix Ltd. buy krebskrebs

Novonix Ltd.
Start price
€2.42
22.02.21 / 50%
Target price
€3.00
22.02.22
Performance (%)
39.59%
End price
€3.38
23.02.22
Summary
This prediction ended on 23.02.22 with a price of €3.38. The BUY prediction by krebskrebs for Novonix Ltd. saw massive gains of 39.59%. krebskrebs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Novonix Ltd. - - - -
iShares Core DAX® -0,87 % 5,32 % 6,86 % 65,21 %
iShares Nasdaq 100 -0,38 % 1,98 % 25,70 % 90,33 %
iShares Nikkei 225® -1,68 % 1,95 % 41,44 % 80,62 %
iShares S&P 500 -0,65 % 2,07 % 21,40 % 70,74 %

Comments by krebskrebs for this prediction

In the thread Novonix Ltd. diskutieren
Prediction Buy
Perf. (%) 39.59%
Target price 3.000
Change
Ends at

Buy mit Kursziel 3,0

krebskrebs 
0
Report Share
22.02.21
In the thread Trading Novonix Ltd.
Prediction Buy
Perf. (%) 39.59%
Target price 3.000
Change
Ends at 22.02.22

Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

krebskrebs 
0
Report Share
23.02.22